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E. Xanthoma disseminatum (XD)

Answers:
A. Xanthelasma e Incorrect. Xanthelasmas are noninflammatory soft yellow-orange cholesterolcontaining lesions usually present on the eyelids. Histologically, xanthelasmas contain foam cells in the papillary dermis.
B. NXG e Correct. NXG usually presents with multiple asymptomatic lesions. Lesions of NXG typically first appear on the trunk or extremities in 60% to 70% of patients, then eventually progress to characteristic periorbital involvement in 80% to 85% of cases. Patients commonly present with an indurated papule, nodule, or plaque with a yellowish hue sometimes with telangiectasias, atrophy, or ulceration. Histologically, palisading granulomas are usually seen in the dermis. The granulomas often contain lipidized histiocytes (foam cells), giant cells, plasma cells, and cholesterol clefts.
C. NL e Incorrect. NL presents as an evolving lesion beginning with red to brown papules or plaques progressing into an atrophic, telangiectatic, yellow lesion. NL and NXG share similar features microscopically including hyalinized collagen within the necrobiotic area. However, NXG often displays Touton cells and atypical giant cells and may be distinguished histologically by cholesterol clefts within the granuloma. NL displays lipids altering with collagen bundles causing a layering of hyalinized collagen described as a wedding cake appearance. E. XD e Incorrect. XD manifests with an eruption of hundreds of yellow, red, or brown papules that tend to cluster. The lesions are often symmetrical and affect the face, trunk, and intertriginous areas of the extremities. A. Diabetes mellitus e Incorrect. NL has been classically associated with diabetes mellitus. The reported prevalence of diabetes mellitus in patients with NL ranges from 11% to 65%. C. Multiple myeloma or MGUS e Correct. The etiology of the NXG is unclear; however, up to 80% of patients can have associated monoclonal gammopathies, most commonly IgG-k; this can precede or follow the onset of cutaneous lesions by many years. 3 In this patient, serum protein electrophoresis was significant for an elevated serum monoclonal protein at 0.34 g/dL (normal range, #0). Immunofixation identified a monoclonal protein band composed of IgG-l. MGUS was subsequently diagnosed.
D. DI e Incorrect. DI is associated with XD in approximately 40% of cases. 4 However, DI is usually mild in these patients and is amenable to treatment with vasopressin. 4 E. Hyperlipidemia e Incorrect. Hyperlipidemia has been associated with xanthelasmas in about 50% of patients. A. Observation e Incorrect. Observation is an appropriate option for patients with NXG. Our patient was referred to hematology-oncology for further workup. The patient elected to be closely monitored in lieu of pursuing treatment, as her lesions remained stable in size, and her MGUS had not progressed.
B. Alkylating chemotherapeutic agents e Incorrect. Alkylating chemotherapeutic agents are the most common systemic treatment for NXG, especially Chlorambucil, which is used in low doses for patients with associated paraproteinemia. 6 C. Corticosteroids e Incorrect. Topical steroids may be used for small NXG areas, and intralesional injections have been used with mixed results. Systemic corticosteroids as monotherapy display a high relapse rate after discontinuation. Systemic corticosteroids may be used in combination with alkylating agents. 6 D. Intravenous Immunoglobulin e Incorrect. Intravenous immunoglobulin has shown rapid remission in patients with NXG and an underlying hematologic disorder. 6 If other treatment modalities fail, intravenous immunoglobulin may be considered. 6 E. Antimetabolites (methotrexate or azathioprine) e Correct. The use of antimetabolites has not proven to be an effective treatment option. Antimetabolites have not been studied since the 1980s and at the time had only produced a partial remission of symptoms. Ultimately, a patient who received both methotrexate and azathioprine actually experienced additional lesions. 6 Antimetabolites have not been included in recent treatment regimens.
Abbreviations used:
DI: diabetes insipidus MGUS: monoclonal gammopathy of undetermined significance NL: necrobiosis lipoidica NXG: necrobiotic xanthogranuloma XD: xanthoma disseminatum
